US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Invesco Floating Rate Municipal Income ETF

24.86

+0.00500.02%

Post-market: 24.910.0550+0.22%16:10 EDT

Volume:1.09K

Turnover:26.96K

Market Cap:31.07M

PE:- -

High:24.91

Open:24.79

Low:24.79

Close:24.85

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients

Microbot Medical announces ACCESS-PVI trial met primary endpoint

REMINDER: Microbot Medical Announces Data from the Company’s ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

ABT Stock to Gain From Early CE Mark Approval of Volt PFA System

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PVI"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PVI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVI\",,,,,undefined,":{"symbol":"PVI","market":"US","secType":"STK","nameCN":"Invesco Floating Rate Municipal Income ETF","latestPrice":24.855,"timestamp":1753732800000,"preClose":24.85,"halted":0,"volume":1086,"hourTrading":{"tag":"盘后","latestPrice":24.91,"preClose":24.855,"latestTime":"16:10 EDT","volume":6,"amount":149.13,"timestamp":1753733404381},"delay":0,"floatShares":1250000,"shares":1250000,"eps":0,"marketStatus":"Not Yet Opened","change":0.005,"latestTime":"07-28 16:00:00 EDT","open":24.79,"high":24.91,"low":24.79,"amount":26962.6356,"amplitude":0.004829,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753776000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":24.85,"sharesOutstanding":1250000,"nav":24.81254,"aum":31015675,"dividendRate":0.023335,"bidAskSpread":0.004817,"postHourTrading":{"tag":"盘后","latestPrice":24.91,"preClose":24.855,"latestTime":"16:10 EDT","volume":6,"amount":149.13,"timestamp":1753733404381},"volumeRatio":0.079858},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVI\",,,,,undefined,":{"symbol":"PVI","floatShares":1250000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.079858,"shares":1250000,"dividePrice":0.58,"high":24.91,"amplitude":0.004829,"preClose":24.85,"low":24.79,"week52Low":24.34,"pbRate":"--","week52High":25.37,"institutionHeld":0,"latestPrice":24.855,"eps":0,"divideRate":0.023335,"volume":1086,"delay":0,"ttmEps":0,"open":24.79,"prevYearClose":24.71,"prevWeekClose":24.85,"prevMonthClose":24.7868,"prevQuarterClose":24.7868,"fiveDayClose":24.82,"twentyDayClose":24.855,"sixtyDayClose":24.82},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PVI\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PVI\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530117041","title":"Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2530117041","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530117041?lang=en_us&edition=fundamental","pubTime":"2025-04-27 07:20","pubTimestamp":1745709600,"startTime":"0","endTime":"0","summary":"One-year clinical trial data for the next-generation, investigational, Sphere-360 single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal Afib. Dual-energy , focal Sphere-9 catheter demonstrates efficacy for linear ablation in persistent AFib. Medtronic continues legacy of leadership in innovation, showcasing arrhythmia management portfolio at Heart Rhythm Society annual meeting. GALWAY, Ireland and SAN DIEGO, April 26, 2025 /PRNewswire/ -- Medtronic plc , a global leader in healthcare technology, today announced positive clinical outcomes from two studies in atrial fibrillation  patients treated with the Affera family of technologies, including the next-generation Sphere-360 single-shot pulsed field ablation  catheter and the groundbreaking Sphere-9 combination mapping and dual-energy focal PFA catheter. Data were presented in High Impact Science Sessions at the Heart Rhythm Society 2025 Annual Meeting in San Diego; the Sphere-360 study was ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/medtronic-affera-pulsed-field-ablation-232000945.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medtronic-affera-pulsed-field-ablation-232000945.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0265550359.USD","PVI","LU2023251221.USD","LU2089283258.USD","LU0072461881.USD","LU1116320901.HKD","LU0976567544.SGD","BK4588","BK4533","LU0265550946.USD","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","LU2111349929.HKD","LU0320765489.SGD","BK4585","LU1571399168.USD","LU0158827948.USD","IE00BQXX3D17.EUR","LU1989771016.USD","IE000M9KFDE8.USD","LU1291159041.SGD","LU1116320737.USD","LU0162691827.USD","PAF","BK4566","LU0211326755.USD","LU1989764664.SGD","LU2271345857.HKD","BK4082","IE00BFXG1179.USD","IE00B3T34201.USD","LU2089284900.SGD","LU0211326839.USD","LU0070302665.USD","LU2089984988.USD","LU0208291251.USD","LU2468319806.SGD","LU1989764748.USD","LU0158827781.USD","LU0496365809.HKD","LU2028103732.USD","MDT","LU0211331839.USD","LU1983299246.USD"],"gpt_icon":0},{"id":"2526366528","title":"Microbot Medical announces ACCESS-PVI trial met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2526366528","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526366528?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:37","pubTimestamp":1744202222,"startTime":"0","endTime":"0","summary":"Microbot Medical (MBOT) presented for the first time the data from its ACCESS-PVI pivotal trial at the Society of Interventional Radiology annual m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/microbot-medical-announces-access-pvi-trial-met-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/microbot-medical-announces-access-pvi-trial-met-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PVI","BK4082","MBOT"],"gpt_icon":0},{"id":"2524115783","title":"REMINDER: Microbot Medical Announces Data from the Company’s ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2524115783","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524115783?lang=en_us&edition=fundamental","pubTime":"2025-04-01 20:30","pubTimestamp":1743510600,"startTime":"0","endTime":"0","summary":"Company Reaffirms Expected Timing of FDA Decision With Respect to 510 Clearance of LIBERTY During the Current Second Quarter. BRAINTREE, Mass., April 01, 2025  -- Microbot Medical Inc. , developer of the innovative LIBERTY Endovascular Robotic System, is providing this reminder that data from the Company’s ACCESS-PVI trial will be presented by Francois Cornelis, MD, PhD, FCIRSE, Memorial Sloan Kettering Cancer Center, Department of Radiology. This is the first time data from the study will be presented via a podium presentation, to take place on Wednesday, April 2, 11:33am CT.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/reminder-microbot-medical-announces-data-123000750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["K","BK4585","MBOT","BK4504","PVI","BK4212","BK4082","BK4588"],"gpt_icon":0},{"id":"2524110878","title":"ABT Stock to Gain From Early CE Mark Approval of Volt PFA System","url":"https://stock-news.laohu8.com/highlight/detail?id=2524110878","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524110878?lang=en_us&edition=fundamental","pubTime":"2025-04-01 20:27","pubTimestamp":1743510420,"startTime":"0","endTime":"0","summary":"Abbott ABT recently announced CE Mark approval for the Volt Pulsed Field Ablation  system to treat patients battling atrial fibrillation . The development came earlier than expected, allowing the company to begin commercial PFA cases in the European Union  with physicians who have already gained experience with the Volt PFA system within its PFA clinical studies.The company will further expand the use of Volt in EU markets throughout the second half of this year.After the announcement on March 27, Abbott shares rose 3.7%, closing at $131.35. The company’s EP portfolio has been seeing well-balanced growth across the United States and international markets. The introduction of the Volt PFA system marks a pivotal moment for electrophysiology in Europe. We expect the market sentiment toward ABT stock to remain positive surrounding this development.Abbott holds a market capitalization of $226.88 billion. The company’s earnings yield of 3.9% surpasses the industry’s average yield of 0.3%. AB","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abt-stock-gain-early-ce-122700836.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4213","LU1291159041.SGD","LU0345769631.USD","LU0266013472.USD","LU1153585028.USD","LU1691799644.USD","LU1989764664.SGD","LU2089984988.USD","LU2133065610.SGD","LU2362540622.SGD","LU2468319806.SGD","LU0154236417.USD","LU0211327993.USD","LU1989771016.USD","LU1267930813.SGD","LU0225283273.USD","LU1023059063.AUD","LU1571399168.USD","LU1989772923.USD","LU1267930490.SGD","EP","LU1061106388.HKD","LU2506951875.HKD","BK4175","LU1267930227.SGD","BK4196","IE00BFTCPJ56.SGD","LU2244417387.USD","LU2112291526.USD","ABT","LU0950375773.USD","IE00BJT1NW94.SGD","LU2506952170.USD","IE00BJJMRZ35.SGD","BSX","LU2506951958.HKD","LU2362541513.USD","PVI","LU0187121727.USD","CE","LU1914381329.SGD","CAH","LU0889566641.SGD","LU1989764748.USD","LU0310800965.SGD","LU0353189763.USD","BK4109","LU1983299246.USD","LU0011850046.USD"],"gpt_icon":1}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PVI\",params:#limit:5,,,undefined,":[{"date":"2025-07-21","symbol":"PVI","amount":0.03777,"announcedDate":"2025-07-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-21","defaultRemindTime":1753104600000,"name":"Invesco Floating Rate Municipal Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-25","payableDate":"2025-07-21","currency":"USD","dateTimestamp":1753070400000,"payDate":"2025-07-25"},{"date":"2025-06-23","symbol":"PVI","amount":0.04509,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Floating Rate Municipal Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-05-19","symbol":"PVI","amount":0.06158,"announcedDate":"2025-05-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-19","defaultRemindTime":1747661400000,"name":"Invesco VRDO Tax-Free ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-23","payableDate":"2025-05-19","currency":"USD","dateTimestamp":1747627200000,"payDate":"2025-05-23"},{"date":"2025-04-21","symbol":"PVI","amount":0.04607,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-21","defaultRemindTime":1745242200000,"name":"Invesco VRDO Tax-Free ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-25","payableDate":"2025-04-21","currency":"USD","dateTimestamp":1745208000000,"payDate":"2025-04-25"},{"date":"2025-03-24","symbol":"PVI","amount":0.03108,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"Invesco VRDO Tax-Free ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-28"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PVI\",market:\"US\",,,undefined,":[{"executeDate":"2015-08-14","recordDate":"2015-08-18","paymentDate":"2015-08-31","value":0.00005,"currency":"USD"},{"executeDate":"2015-09-15","recordDate":"2015-09-17","paymentDate":"2015-09-30","value":0.00005,"currency":"USD"},{"executeDate":"2015-10-15","recordDate":"2015-10-19","paymentDate":"2015-10-30","value":0.00005,"currency":"USD"},{"executeDate":"2015-11-13","recordDate":"2015-11-17","paymentDate":"2015-11-30","value":0.00005,"currency":"USD"},{"executeDate":"2015-12-15","recordDate":"2015-12-17","paymentDate":"2015-12-31","value":0.00005,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PVI\",market:\"US\",delay:false,,,undefined,":{}}}